György Marko-Varga

Further involvements

• Mon, Oct 21

  11:29 – 11:41 10 Min. 2 Min.

  • Oral presentation
  • OP-03

  Integrating AI-based Digital Pathology and Proteome Profiling to Uncover Melanoma Progression and Heterogeneity

   Clinical Proteomics
• Mon, Oct 21

  • Poster presentation
  • P-I-0324

  Proteomic signatures of Mitochondrial and immune responses as predictors of melanoma evolution

   Clinical Proteomics
• Mon, Oct 21

  • Poster presentation
  • P-I-0215

  Mitochondrial dynamics in gastric cancer: contrasting diffuse and intestinal types

   Population Proteomics in Health and Disease
• Mon, Oct 21

  • Poster presentation
  • P-I-0267

  Investigation of antiangiogenic tyrosine kinase inhibitors in primary and metastatic tumor models

   Spatial and Imaging Proteomics
• Tue, Oct 22

  • Poster presentation
  • P-II-0621

  Harmonization of quantitative proteomics data collected across the international cancer proteogenome consortium

   Clinical Proteomics
• Tue, Oct 22

  • Poster presentation
  • P-II-0532

  Proteomic profiling of paired primary tumors and brain metastases from lung adenocarcinoma patients uncovers phenotypic changes during disease progression

   Multiomics Approaches
• Tue, Oct 22

  • Poster presentation
  • P-II-0648

  The European cancer moonshot "Biobank" – the heart of cancer studies

   Clinical Proteomics
• Tue, Oct 22

  • Poster presentation
  • P-II-0707

  Morphological and molecular profiling as a pilar of precision medicine: tailoring treatment in late-stage cancer patients

   Clinical Proteomics